Clinical Trial Update: Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2) [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial evaluating niacinamide for polycystic kidney disease has completed (NIAC-PKD2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Kidney Disease

Drugs mentioned

• Niacinamide (nicotinamide)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Polycystic Kidney Disease | Phase 2 | Status: COMPLETED